{"id":"https://openalex.org/W2889044756","doi":"https://doi.org/10.1124/jpet.118.251116","title":"Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction","display_name":"Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction","publication_year":2018,"publication_date":"2018-08-31","ids":{"openalex":"https://openalex.org/W2889044756","doi":"https://doi.org/10.1124/jpet.118.251116","mag":"2889044756","pmid":"https://pubmed.ncbi.nlm.nih.gov/30171039"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.118.251116","doi":"https://doi.org/10.1124/jpet.118.251116","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.118.251116","pdf_url":"https://jpet.aspetjournals.org/content/jpet/367/2/292.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jpet.aspetjournals.org/content/jpet/367/2/292.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yong-Xin Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yong-Xin Li","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California li_yongxin@allergan.com afoster@otonomy.com","Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California li_yongxin@allergan.com afoster@otonomy.com","institution_ids":[]},{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102237248","display_name":"Jiaying Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jia-Ying Yang","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075248729","display_name":"Miguel Alcantara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miguel Alcantara","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074075078","display_name":"Grigor Abelian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grigor Abelian","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077970617","display_name":"Ashutosh A. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashutosh Kulkarni","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052508274","display_name":"Ursula V. Staubli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ursula Staubli","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056598194","display_name":"Alan C. Foster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan C. Foster","raw_affiliation_strings":["Department of Biological Sciences, Allergan, Inc., Irvine, California li_yongxin@allergan.com afoster@otonomy.com","Department of Biological Sciences, Allergan, Inc., Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California li_yongxin@allergan.com afoster@otonomy.com","institution_ids":[]},{"raw_affiliation_string":"Department of Biological Sciences, Allergan, Inc., Irvine, California","institution_ids":["https://openalex.org/I4210139498"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210139498"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":{"value":3750,"currency":"USD","value_usd":3750},"fwci":0.4361,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.49477683,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"367","issue":"2","first_page":"292","last_page":"301"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asct1","display_name":"ASCT1","score":0.9729999899864197},{"id":"https://openalex.org/keywords/asct2","display_name":"ASCT2","score":1.0},{"id":"https://openalex.org/keywords/neutral-amino-acid-transporter","display_name":"neutral amino acid transporter","score":0.9330000281333923},{"id":"https://openalex.org/keywords/d-serine","display_name":"D-serine","score":0.8429999947547913},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.5400000214576721},{"id":"https://openalex.org/keywords/visual-dysfunction","display_name":"visual dysfunction","score":0.9350000023841858},{"id":"https://openalex.org/keywords/retinal-degeneration","display_name":"retinal degeneration","score":0.9729999899864197},{"id":"https://openalex.org/keywords/amphetamine-induced-hyperlocomotion","display_name":"amphetamine-induced hyperlocomotion","score":0.8889999985694885},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.8489999771118164},{"id":"https://openalex.org/keywords/plasma-bioavailability","display_name":"plasma bioavailability","score":0.8330000042915344},{"id":"https://openalex.org/keywords/transporter-inhibitors","display_name":"transporter inhibitors","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.754054844379425},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6349726915359497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5617262125015259},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.5448101162910461},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49453064799308777},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3452529311180115},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3307685852050781},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.30433738231658936},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23673659563064575},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.23260486125946045},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11676007509231567},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10339319705963135},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06748488545417786}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008124","descriptor_name":"Locomotion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012694","descriptor_name":"Serine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014786","descriptor_name":"Vision Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014786","descriptor_name":"Vision Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015778","descriptor_name":"Minor Histocompatibility Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020318","descriptor_name":"Rats, Long-Evans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026962","descriptor_name":"Amino Acid Transport System ASC","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/jpet.118.251116","doi":"https://doi.org/10.1124/jpet.118.251116","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.118.251116","pdf_url":"https://jpet.aspetjournals.org/content/jpet/367/2/292.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:30171039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30171039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1124/jpet.118.251116","doi":"https://doi.org/10.1124/jpet.118.251116","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.118.251116","pdf_url":"https://jpet.aspetjournals.org/content/jpet/367/2/292.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2889044756.pdf","grobid_xml":"https://content.openalex.org/works/W2889044756.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1013516912","https://openalex.org/W2012015068","https://openalex.org/W2018278299","https://openalex.org/W2027517558","https://openalex.org/W2034140302","https://openalex.org/W2034984029","https://openalex.org/W2036546405","https://openalex.org/W2039872800","https://openalex.org/W2047901827","https://openalex.org/W2057050792","https://openalex.org/W2078782608","https://openalex.org/W2084038314","https://openalex.org/W2085223461","https://openalex.org/W2118257266","https://openalex.org/W2121683187","https://openalex.org/W2146870579","https://openalex.org/W2152525754","https://openalex.org/W2165209294","https://openalex.org/W2170461909","https://openalex.org/W2171792157","https://openalex.org/W2339017320","https://openalex.org/W2414332321","https://openalex.org/W2417905352","https://openalex.org/W2460840553","https://openalex.org/W2477706982","https://openalex.org/W2547465790","https://openalex.org/W2744486554","https://openalex.org/W4236811700"],"related_works":["https://openalex.org/W2744486554","https://openalex.org/W2437457693","https://openalex.org/W2890066048","https://openalex.org/W3025552418","https://openalex.org/W1991091584","https://openalex.org/W2066830945","https://openalex.org/W1987863549","https://openalex.org/W2417905352","https://openalex.org/W984426630","https://openalex.org/W2137611788"],"abstract_inverted_index":{"-methyl-d-aspartate":[0],"receptor":[1],"coagonist":[2],"d-serine":[3],"is":[4],"a":[5,158],"substrate":[6],"for":[7,35,87],"the":[8,23,112,134,153,164,172],"neutral":[9],"amino":[10],"acid":[11],"transporters":[12,170],"ASCT1":[13,32,167],"and":[14,33,43,60,73,89,108,116,126,168],"ASCT2,":[15],"which":[16,46],"may":[17],"regulate":[18],"its":[19],"extracellular":[20],"levels":[21],"in":[22,38,100,123,136,139,171],"central":[24],"nervous":[25],"system":[26],"(CNS).":[27],"We":[28],"tested":[29],"inhibitors":[30],"of":[31,41,83,130,149,166],"ASCT2":[34,169],"their":[36],"effects":[37],"rodent":[39],"models":[40],"schizophrenia":[42],"visual":[44,121],"dysfunction,":[45],"had":[47],"previously":[48],"been":[49],"shown":[50],"to":[51,54,71,151,161],"be":[52],"responsive":[53],"d-serine.":[55],"L-4-fluorophenylglycine":[56],"(L-4FPG),":[57],"L-4-hydroxyPG":[58],"(L-4OHPG),":[59],"L-4-chloroPG":[61],"(L-4ClPG)":[62],"all":[63],"showed":[64,76],"high":[65],"plasma":[66],"bioavailability":[67],"when":[68],"administered":[69,94],"systemically":[70],"rats":[72,142],"mice.":[74],"L-4FPG":[75,95,115,131,150],"good":[77],"brain":[78,154],"penetration":[79],"with":[80],"brain/plasma":[81],"ratios":[82],"0.7-1.4;":[84],"however,":[85],"values":[86],"L-4OHPG":[88,103,117],"L-4ClPG":[90,109],"were":[91],"lower.":[92],"Systemically":[93],"potently":[96],"reduced":[97],"amphetamine-induced":[98],"hyperlocomotion":[99],"mice,":[101],"whereas":[102],"was":[104],"100-fold":[105],"less":[106],"effective":[107],"inactive":[110],"at":[111],"doses":[113],"tested.":[114],"did":[118],"not":[119],"impair":[120],"acuity":[122],"naive":[124],"rats,":[125],"acute":[127],"systemic":[128],"administration":[129],"significantly":[132],"improved":[133],"deficit":[135],"contrast":[137],"sensitivity":[138],"blue":[140],"light-treated":[141],"caused":[143],"by":[144],"retinal":[145],"degeneration.":[146],"The":[147],"ability":[148],"penetrate":[152],"makes":[155],"this":[156],"compound":[157],"useful":[159],"tool":[160],"further":[162],"evaluate":[163],"function":[165],"CNS.":[173]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-09-07T00:00:00"}